Literature DB >> 27324785

The Expression of VHL (Von Hippel-Lindau) After Traumatic Spinal Cord Injury and Its Role in Neuronal Apoptosis.

Jie Hao1,2, Xiaoqing Chen2, Ting Fu3, Jie Liu1,2, Mingchen Yu1,2, Wei Han1,2, Shuang He4, Rong Qian1,2, Feng Zhang5.   

Abstract

The VHL (Von Hippel-Lindau) gene is a tumor suppressor gene, which is best known as an E3 ubiquitin ligase that negatively regulates the hypoxia inducible factor. The inactivation of VHL gene could result in the abnormal synthesis of VHL protein, which is in contact with the development and occurrence of renal clear cell carcinoma. However, the expression and possible function of VHL in central nervous system (CNS) is still unclear. To examine the function of VHL in CNS injury and repair, we used an acute spinal cord injury (SCI) model in adult rats. Western blot analysis showed an important upregulation of VHL protein, reaching a peak at day 3 and then declined during the following days. Double immunofluorescence staining showed that VHL was co-expressed with neurons, but not with astrocytes and microglia. Moreover, we detected that active caspase-3 had co-localized with VHL in neurons after SCI. Additionally in vitro, VHL depletion, by short interfering RNA, significantly reduced neuronal apoptosis. In conclusion, these data suggested that the change of VHL protein expression was related to neuronal apoptosis after SCI.

Entities:  

Keywords:  Apoptosis; Neuron; Spinal cord injury; Von Hippel-Lindau

Mesh:

Substances:

Year:  2016        PMID: 27324785     DOI: 10.1007/s11064-016-1952-7

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  32 in total

1.  Neuronal and glial apoptosis after traumatic spinal cord injury.

Authors:  X Z Liu; X M Xu; R Hu; C Du; S X Zhang; J W McDonald; H X Dong; Y J Wu; G S Fan; M F Jacquin; C Y Hsu; D W Choi
Journal:  J Neurosci       Date:  1997-07-15       Impact factor: 6.167

2.  Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist.

Authors:  S Wada; K Yone; Y Ishidou; T Nagamine; S Nakahara; T Niiyama; T Sakou
Journal:  J Neurosurg       Date:  1999-07       Impact factor: 5.115

3.  E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity.

Authors:  Jee H Lee; Chris Elly; Yoon Park; Yun-Cai Liu
Journal:  Immunity       Date:  2015-06-16       Impact factor: 31.745

4.  Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.

Authors:  Á Ordóñez-Navadijo; E Fuertes-Yebra; B Acosta-Iborra; E Balsa; A Elorza; J Aragonés; M O Landazuri
Journal:  Oncogene       Date:  2015-04-27       Impact factor: 9.867

5.  Novel Homozygous Mutation of the Internal Translation Initiation Start Site of VHL is Exclusively Associated with Erythrocytosis: Indications for Distinct Functional Roles of von Hippel-Lindau Tumor Suppressor Isoforms.

Authors:  Marije Bartels; Marieke M van der Zalm; Brigitte A van Oirschot; Frank S Lee; Rachel H Giles; Marieke J H A Kruip; Jerney J J M Gitz-Francois; Wouter W Van Solinge; Marc Bierings; Richard van Wijk
Journal:  Hum Mutat       Date:  2015-08-17       Impact factor: 4.878

6.  Hydroxyl radicals generated in the rat spinal cord at the level produced by impact injury induce cell death by necrosis and apoptosis: protection by a metalloporphyrin.

Authors:  F Bao; D Liu
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Dexmedetomidine attenuates isoflurane-induced cognitive impairment through antioxidant, anti-inflammatory and anti-apoptosis in aging rat.

Authors:  Xiaoning Wang; Binjiang Zhao; Xue Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

8.  Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status.

Authors:  Yosra Messai; Sophie Gad; Muhammad Zaeem Noman; Gwenael Le Teuff; Sophie Couve; Bassam Janji; Solenne Florence Kammerer; Nathalie Rioux-Leclerc; Meriem Hasmim; Sophie Ferlicot; Véronique Baud; Arnaud Mejean; David Robert Mole; Stéphane Richard; Alexander M M Eggermont; Laurence Albiges; Fathia Mami-Chouaib; Bernard Escudier; Salem Chouaib
Journal:  Eur Urol       Date:  2015-12-23       Impact factor: 20.096

9.  The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform.

Authors:  F Chesnel; P Hascoet; J P Gagné; A Couturier; F Jouan; G G Poirier; C Le Goff; C Vigneau; Y Danger; F Verite; X Le Goff; Y Arlot-Bonnemains
Journal:  Br J Cancer       Date:  2015-06-02       Impact factor: 7.640

10.  Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo.

Authors:  Junfang Wu; Giorgi Kharebava; Chunshu Piao; Bogdan A Stoica; Michael Dinizo; Boris Sabirzhanov; Marie Hanscom; Kelsey Guanciale; Alan I Faden
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  3 in total

1.  Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice.

Authors:  Ying Wang; Jingyun Yang; Guhong Du; Dexuan Ma; Liangfu Zhou
Journal:  Mol Carcinog       Date:  2017-06-30       Impact factor: 4.784

Review 2.  Considerations about Hypoxic Changes in Neuraxis Tissue Injuries and Recovery.

Authors:  Simona Isabelle Stoica; Coralia Bleotu; Vlad Ciobanu; Anca Mirela Ionescu; Irina Albadi; Gelu Onose; Constantin Munteanu
Journal:  Biomedicines       Date:  2022-02-18

Review 3.  Degradation of proteins by PROTACs and other strategies.

Authors:  Yang Wang; Xueyang Jiang; Feng Feng; Wenyuan Liu; Haopeng Sun
Journal:  Acta Pharm Sin B       Date:  2019-08-13       Impact factor: 11.413

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.